4//SEC Filing
Ramelmeier Rolf Andrew 4
Accession 0001209191-21-002078
CIK 0001001233other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:27 PM ET
Size
5.9 KB
Accession
0001209191-21-002078
Insider Transaction Report
Form 4
Ramelmeier Rolf Andrew
EVP, Technical Operations
Transactions
- Sale
Common Stock
2020-12-31$16.74/sh−2,464$41,247→ 65,978 total
Footnotes (2)
- [F1]Included in this total are: (a) 8,333 shares from the Reporting Person's February 25, 2019 restricted stock unit (RSU) grant that will vest in two remaining annual installments on February 25, 2021 and February 25, 2022, resulting in such RSU grant being vested in full on the third (3rd) anniversary of the grant date; and (b) 55,000 shares from the Reporting Person's February 25, 2020 RSU grant that will vest in three annual installments on February 25, 2021, February 25, 2022 and February 25, 2023, resulting in such RSU grant being vested in full on the third (3rd) anniversary of the grant date.
- [F2]All such RSUs are granted pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP, as amended") and vested or will vest with respect to 1/3rd of the shares in each respective RSU grant in three equal annual installments over the three-year period measured from the dates of grant, subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001789340
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:27 PM ET
- Size
- 5.9 KB